Consolidated Balance Sheets - USD ($)	Feb. 28, 2017	Feb. 29, 2016
CURRENT ASSETS
Cash and cash equivalents	$ 782,707	$ 363,783
Note receivable	0	125,000
Prepaid expenses	20,856	33,121
Total Current Assets	803,563	521,904
Equipment (net of accumulated depreciation of $265,234 and $169,396, respectively)	414,635	497,052
Refundable deposits	43,600	43,600
TOTAL ASSETS	1,261,798	1,062,556
Current liabilities
Accounts payable	572,195	746,144
Accrued expenses	179,680	214,311
Deferred research & development reimbursement	177,517	0
Notes payable (net of debt discount of $743,282)	0	1,533,120
Convertible note payable (net of debt discount of $10,914)	989,086	0
Accrued interest payable	15,890	56,000
Accrued dividends on Series B Preferred Stock	15,638	48,317
Total Current Liabilities	1,950,006	2,597,892
Warrant liability	2,106,972	234,461
Total Liabilities	4,056,978	2,832,353
STOCKHOLDERS' DEFICIT
Common Stock, ($0.0001 par value; 150,000,000 shares authorized; 4,707,942 and 1,851,201 shares issued and outstanding, respectively)	471	185
Additional Paid-in-capital	23,523,140	21,607,259
Accumulated deficit	(26,318,885)	(23,377,328)
Total stockholders' deficit	(2,795,180)	(1,769,797)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	1,261,798	1,062,556
Series A Preferred Stock [Member]
STOCKHOLDERS' DEFICIT
Convertible Preferred Stock	87	87
Series A-2 Preferred Stock [Member]
STOCKHOLDERS' DEFICIT
Convertible Preferred Stock	7	0
Series B Preferred Stock [Member]
STOCKHOLDERS' DEFICIT
Convertible Preferred Stock	$ 0	$ 0